Green Synthesis of Magnetite Nanoparticles (via Thermal Decomposition Method) with Controllable Size and Shape

Magnetite (Fe3O4) nanoparticles with controllable size and shape were synthesized by the thermal decomposition method. In contrast to previously reported thermal decomposition methods, our synthesis method had utilized a much cheaper and less toxic iron precursor, iron acetylacetonate (Fe(acac)3), and environmentally benign and non-toxic polyethylene oxide (PEO) was being used as the solvent and surfactant simultaneously. Fe3O4 nanoparticles of controllable size and shape were prepared by manipulating the synthesis parameters such as precursor concentrations, reaction durations and surfactants

Repeated doses of melatonin protects against focal cerebral ischemia in the rat

We studied the time window of neuroprotection against focal ischemia by a single dose or repeated doses of melatonin (MT) at 5 mg/kg. Adult male Sprague-Dawley rats (280 to 360 g) were anesthetized with sodium pentobarbital (60 mg/kg, I.P.) to undergo reversible right-sided endovascular middle cerebral artery occlusion (MCAO) for 3 hours. Arterial blood pressure, heart rate and cerebral blood flow were monitored, and rectal temperature was kept between 36.5 and 37.5 ºC throughout anesthesia. The control rats received 1 I.P. dose of the vehicle at the onset of ischemia, whereas experimental groups of rats received either 1 I.P. dose of MT at 0 or 60 minutes after onset of ischemia or 3 doses of MT at 1, 24, and 48 hours after onset of ischemia. The rats were decapitated on day 3 of MCAO, and their brains were stained with 2% triphenyltetrazolium chloride for determination of infarction. Results were compared using 2-tailed student’s t test. When compared to the relative infarct volume of 27.0±4.6% (mean±SEM; 7 rats) in the control group, a single (5 mg/kg) I.P. dose of MT did not significantly reduce the relative infarct volume (20.1±4.1% in the 0-minute group [8 rats]; 19.8±3.2% in the 60-minute group [9 rats]). Nevertheless, the relative infarct volume was significantly reduced to 13.9±3.4% (8 rats, P < 0.05) in the group which received 3 doses of MT. There was no significant difference in hemodynamic parameters among the groups. Thus, repeated doses rather than a single dose of exogenous MT protects against focal cerebral ischemia, when given 60 minutes after onset of ischemia. Supported by the CRCG Research Grant 10202138 of the University of Hong Kongpublished_or_final_versio

In vivo neuroprotection of melatonin against focal cerebral ischaemia in the rat

published_or_final_versio

Ontogeny of 2-[ 125I]iodomelatonin binding sites in the chicken (Gallus domesticus) kidney and spleen

To understand the possible role of melatonin receptors in the development of renal and immune functions, age-related variations of 2-[ 125I]iodomelatonin binding sites in the chicken kidney and spleen were investigated by radioreceptor assay. Chickens at embryonic day 20, as well as 2 days, 9 days, 2 weeks, 6 weeks, 12 weeks, and 16 weeks after hatching, were kept under a 12 h light : 12 h dark photoperiod and killed at the middle of the light period. Binding sites for 2-[ 125I]iodomelatonin in membrane preparations of the chicken kidney and spleen were present on embryonic day 20. The maximum binding densities (B(max)) in the kidney increased to a peak between 9 days and 2 weeks of age, then progressively decreased. B(max) values of 2-[ 125I]iodomelatonin binding sites in the chicken spleen were lower than in the kidney. The peak density in the chicken spleen was recorded at day 2 after hatching and decreased significantly after 6 weeks of age. There were no significant differences in binding affinities (K(d)) in kidney and spleen of chicken in the different age groups studied. The unity of Hill coefficients of 2-[ 125I]iodomelatonin binding sites of the chicken kidney and spleen in all age groups tested suggested that only a single class of binding sites was present in these tissues during development. It is proposed that the developmental changes in 2-[ 125I]iodomelatonin binding sites in the chicken kidney and spleen may be pertinent to the development of diurnal rhythms of kidney functions and the post-pubertal decline in immune functions of the chicken.published_or_final_versio

Melatonin pretreatment protects against focal cerebral ischemia in the rat

Melatonin (MT) possesses many properties of an ideal neuroprotectant. In this study, the neuroprotective effects of exogenous MT were tested in a middle cerebral artery occlusion (MCAO) stroke model. Adult male Sprague-Dawley rats (280 to 360 g) were anesthetized with sodium pentobarbital (60 mg/kg, I.P.) to undergo reversible right-sided endovascular MCAO for 3 hours. Arterial blood pressure, heart rate and cerebral blood flow (CBF) were monitored, and rectal temperature was kept between 36.5 and 37.5 ºC throughout anesthesia. One I.P. dose of MT (at 1.5, 5, or 15 mg/kg) or the vehicle was given 30 minutes before onset of ischemia. The rats were decapitated on day 3 of MCAO, and their brains were stained with 2% triphenyltetrazolium chloride for determination of infarction. Results were compared using 2-tailed student’s t test. When compared to the relative infarct volume of 31.8±3.3% (mean±SEM; 16 rats) in the control group, treatment with MT reduced the relative infarct volume in a dose-dependent manner (30.5±3.2% in the 1.5 mg/kg group [17 rats]; 15.9±2.2% in the 5 mg/kg group [16 rats], P < 0.05; 21.4±3.0% in the 15 mg/kg group [15 rats], P < 0.05). There was no significant difference in heart rate, arterial blood pressure and CBF among the groups. We concluded that a single dose of MT between 5 and 15 mg/kg protects against focal cerebral ischemia, when given 30 minutes before onset of ischemia. The above doses of MT do not produce significant hemodynamic effects nor alter the CBF during ischemia and reperfusion. Supported by the CRCG Research Grant 10202138 of the University of Hong Kongpublished_or_final_versio

Anti-tumorigenic and Pro-apoptotic effects of CKBM on gastric cancer growth in nude mice

Natural botanical products can be integrated with western medicine to optimize the treatment outcome, increase immune function and minimize the side effects from western drug treatment. CKBM is a combination of herbs and yeasts formulated based on traditional Chinese medicinal principles. Previous study has demonstrated that CKBM is capable of improving immune responsiveness through the induction of cytokine mediators, such as TNF-α and IL-6. In this study, we aimed to investigate the effect of this immunomodulatory drug on gastric cancer growth using a human xenograft model. Gastric cancer tissues were implanted subcutaneously into athymic nude mice followed by a 14-day or 28-day of CKBM treatment. Results showed that higher doses of CKBM (0.4 or 0.8 ml/mouse/day) produced a dose-dependent inhibitory effect on gastric tumor growth after 28-day drug treatment. This was associated with a decrease of cellular proliferation by 30% with concomitant increase in apoptosis by 97% in gastric tumor cells when compared with the control group. In contrast, CKBM showed no effect on angiogenesis in gastric tumors. This study demonstrates the anti-tumorigenic action of CKBM on gastric cancer probably via inhibition of cell proliferation and induction of apoptosis, and provides future potential targets of this drug candidate on cancer therapy.published_or_final_versio

Development of human single-chain antibodies against SARS-associated coronavirus.

The outbreak of severe acute respiratory syndrome (SARS), caused by a distinct coronavirus, in 2003 greatly threatened public health in China, Southeast Asia as well as North America. Over 1,000 patients died of the SARS virus, representing 10% of infected people. Like other coronaviruses, the SARS virus also utilizes a surface glycoprotein, namely the spike protein, to infect host cells. The spike protein of SARS virus consists of 1,255 amino acid residues and can be divided into two sub-domains, S1 and S2. The S1 domain mediates the binding of the virus to its receptor angiotensin-converting enzyme 2, which is abundantly distributed on the surface of human lung cells. The S2 domain mediates membrane fusion between the virus and the host cell. Hence two strategies can be used to block the infection of the SARS virus, either by interfering with the binding of the S1 domain to the receptor or by blocking the fusion of the virus with the cell membrane mediated by the S2 domain. Several antibodies against the S1 domain have been generated and all of them are able to neutralize the virus in vitro and in vivo using animal models. Unfortunately, point mutations have been identified in the S1 domain, so that the virus isolated in the future may not be recognized by these antibodies. As no mutation has been found in the S2 domain indicating that this region is more conserved than the S1 domain, it may be a better target for antibody binding. After predicting the immunogenicity of the epitopes of the S2 domain, we chemically synthesized two peptides and also expressed one of them using a recombinant DNA method. We screened a phage displaying library of human single-chain antibodies (ScFv) against the predicted epitopes and obtained a human ScFv which can recognize the SARS virus in vitro

Thermodynamics of Dyonic Lifshitz Black Holes

Black holes with asymptotic anisotropic scaling are conjectured to be gravity duals of condensed matter system close to quantum critical points with non-trivial dynamical exponent z at finite temperature. A holographic renormalization procedure is presented that allows thermodynamic potentials to be defined for objects with both electric and magnetic charge in such a way that standard thermodynamic relations hold. Black holes in asymptotic Lifshitz spacetimes can exhibit paramagnetic behavior at low temperature limit for certain values of the critical exponent z, whereas the behavior of AdS black holes is always diamagnetic.Comment: 26 pages, 4 figure

Analytic Lifshitz black holes in higher dimensions

We generalize the four-dimensional R^2-corrected z=3/2 Lifshitz black hole to a two-parameter family of black hole solutions for any dynamical exponent z and for any dimension D. For a particular relation between the parameters, we find the first example of an extremal Lifshitz black hole. An asymptotically Lifshitz black hole with a logarithmic decay is also exhibited for a specific critical exponent depending on the dimension. We extend this analysis to the more general quadratic curvature corrections for which we present three new families of higher-dimensional D>=5 analytic Lifshitz black holes for generic z. One of these higher-dimensional families contains as critical limits the z=3 three-dimensional Lifshitz black hole and a new z=6 four-dimensional black hole. The variety of analytic solutions presented here encourages to explore these gravity models within the context of non-relativistic holographic correspondence.Comment: 14 page

Black holes and black branes in Lifshitz spacetimes

We construct analytic solutions describing black holes and black branes in asymptotically Lifshitz spacetimes with arbitrary dynamical exponent z and for arbitrary number of dimensions. The model considered consists of Einstein gravity with negative cosmological constant, a scalar, and N U(1) gauge fields with dilatonic-like couplings. We study the phase diagrams and thermodynamic instabilities of the solution, and find qualitative differences between the cases with 12.Comment: 27 pages, 10 figures; v2 references added, minor comments adde